Caristo Diagnostics is set to showcase significant advancements in AI-driven cardiovascular technologies at the upcoming SCCT 2026 Annual Scientific Meeting. Notably, three abstracts nominated for the Young Investigator Award will feature findings from the University of Oxford's ORFAN registry, emphasizing the application of the FAI-Score in both contrast and non-contrast cardiac CT scans.
The presentations will explore the enhanced ability of FAI-Score to quantify coronary inflammation, providing a more comprehensive cardiovascular risk assessment compared to traditional methods, such as the coronary calcium score. Key findings include the prognostic value of coronary inflammation imaging and the predictive capabilities of AI in assessing plaque types against histological data from a substantial cohort of patients.
These contributions underscore the growing recognition of AI in improving cardiovascular care and risk stratification. The SCCT meeting will feature expert discussions on integrating these technologies into clinical practice, aiming to refine patient management strategies.
As the field of cardiovascular diagnostics evolves, the insights presented at SCCT 2026 could significantly influence future approaches to early detection and personalized treatment, potentially transforming patient outcomes in cardiovascular health.